| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 12 | 2023 | 380 | 0.980 |
Why?
|
| Adenocarcinoma | 25 | 2022 | 6339 | 0.940 |
Why?
|
| Microsatellite Repeats | 17 | 2005 | 785 | 0.920 |
Why?
|
| DNA Mismatch Repair | 6 | 2022 | 428 | 0.830 |
Why?
|
| Genes, APC | 11 | 2008 | 145 | 0.760 |
Why?
|
| Barrett Esophagus | 3 | 2021 | 492 | 0.750 |
Why?
|
| Appendiceal Neoplasms | 1 | 2023 | 155 | 0.750 |
Why?
|
| Colorectal Neoplasms | 29 | 2022 | 6935 | 0.730 |
Why?
|
| Colonic Neoplasms | 13 | 2016 | 2538 | 0.720 |
Why?
|
| Esophageal Neoplasms | 6 | 2021 | 1649 | 0.610 |
Why?
|
| Base Pair Mismatch | 10 | 2004 | 92 | 0.580 |
Why?
|
| Endometrial Neoplasms | 4 | 2023 | 1365 | 0.560 |
Why?
|
| Tumor Suppressor Protein p53 | 12 | 2021 | 2916 | 0.550 |
Why?
|
| Pancreatic Neoplasms | 23 | 2009 | 5365 | 0.470 |
Why?
|
| Keratins | 3 | 2021 | 497 | 0.470 |
Why?
|
| Jews | 6 | 2003 | 364 | 0.460 |
Why?
|
| Neoplasms, Glandular and Epithelial | 2 | 2012 | 487 | 0.440 |
Why?
|
| Adenomatous Polyposis Coli | 6 | 2008 | 218 | 0.440 |
Why?
|
| Microsatellite Instability | 6 | 2016 | 716 | 0.430 |
Why?
|
| Cytoskeletal Proteins | 8 | 2005 | 1342 | 0.380 |
Why?
|
| O(6)-Methylguanine-DNA Methyltransferase | 2 | 2009 | 83 | 0.380 |
Why?
|
| Loss of Heterozygosity | 5 | 2011 | 662 | 0.330 |
Why?
|
| Dacarbazine | 2 | 2009 | 559 | 0.320 |
Why?
|
| Point Mutation | 4 | 1999 | 1596 | 0.310 |
Why?
|
| Adenoma | 12 | 2015 | 2160 | 0.300 |
Why?
|
| Genes, p53 | 9 | 2007 | 712 | 0.290 |
Why?
|
| Precancerous Conditions | 5 | 2018 | 980 | 0.290 |
Why?
|
| Neuroendocrine Tumors | 3 | 2009 | 641 | 0.290 |
Why?
|
| Genes, ras | 8 | 2007 | 654 | 0.280 |
Why?
|
| DNA, Neoplasm | 15 | 2007 | 1745 | 0.270 |
Why?
|
| Gastritis | 2 | 2023 | 199 | 0.260 |
Why?
|
| Neoplasm Proteins | 11 | 2008 | 3612 | 0.250 |
Why?
|
| MutS Homolog 2 Protein | 15 | 2015 | 197 | 0.250 |
Why?
|
| Cell Transformation, Neoplastic | 9 | 2010 | 2824 | 0.250 |
Why?
|
| Germ-Line Mutation | 10 | 2009 | 1858 | 0.250 |
Why?
|
| Colonic Polyps | 4 | 2022 | 554 | 0.240 |
Why?
|
| DNA Repair | 13 | 2004 | 2045 | 0.240 |
Why?
|
| Immunohistochemistry | 19 | 2021 | 11073 | 0.240 |
Why?
|
| Sentinel Lymph Node Biopsy | 2 | 2006 | 732 | 0.230 |
Why?
|
| Helicobacter heilmannii | 1 | 2023 | 6 | 0.230 |
Why?
|
| DNA-Binding Proteins | 14 | 2015 | 9606 | 0.230 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2012 | 954 | 0.230 |
Why?
|
| Intestinal Neoplasms | 5 | 2008 | 312 | 0.220 |
Why?
|
| Proto-Oncogene Proteins | 12 | 2005 | 4510 | 0.220 |
Why?
|
| Ribonuclease, Pancreatic | 1 | 2023 | 149 | 0.200 |
Why?
|
| Colitis | 3 | 2023 | 1233 | 0.200 |
Why?
|
| Cyclooxygenase 2 Inhibitors | 4 | 2009 | 321 | 0.200 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2021 | 42 | 0.190 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 7 | 2006 | 698 | 0.190 |
Why?
|
| Trans-Activators | 5 | 2005 | 2856 | 0.180 |
Why?
|
| Adenomatous Polyps | 3 | 2008 | 108 | 0.180 |
Why?
|
| Helicobacter pylori | 1 | 2023 | 377 | 0.180 |
Why?
|
| Molecular Targeted Therapy | 1 | 2012 | 2811 | 0.180 |
Why?
|
| Helicobacter Infections | 1 | 2023 | 388 | 0.170 |
Why?
|
| Neoplastic Syndromes, Hereditary | 1 | 2022 | 245 | 0.170 |
Why?
|
| Genetic Techniques | 1 | 2003 | 427 | 0.170 |
Why?
|
| Esophagectomy | 2 | 2021 | 465 | 0.160 |
Why?
|
| Sulfonamides | 5 | 2009 | 1975 | 0.150 |
Why?
|
| Aneuploidy | 2 | 2001 | 551 | 0.150 |
Why?
|
| Pyrazoles | 5 | 2009 | 2007 | 0.150 |
Why?
|
| Adenomyoma | 1 | 1997 | 8 | 0.150 |
Why?
|
| beta Catenin | 7 | 2010 | 1040 | 0.140 |
Why?
|
| Gene Deletion | 8 | 2006 | 2667 | 0.140 |
Why?
|
| Common Bile Duct | 1 | 1997 | 106 | 0.140 |
Why?
|
| Thymidylate Synthase | 1 | 2016 | 74 | 0.140 |
Why?
|
| Gastrectomy | 1 | 2021 | 672 | 0.140 |
Why?
|
| Polymorphism, Genetic | 4 | 2008 | 4287 | 0.140 |
Why?
|
| Mutation | 24 | 2018 | 30045 | 0.140 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 1997 | 120 | 0.140 |
Why?
|
| Cholecystitis | 1 | 1997 | 180 | 0.130 |
Why?
|
| Aged, 80 and over | 24 | 2021 | 58956 | 0.130 |
Why?
|
| Alleles | 8 | 2008 | 6922 | 0.130 |
Why?
|
| Muir-Torre Syndrome | 1 | 2015 | 12 | 0.130 |
Why?
|
| Bile Duct Diseases | 1 | 1996 | 97 | 0.130 |
Why?
|
| Adenomatous Polyposis Coli Protein | 5 | 2006 | 181 | 0.130 |
Why?
|
| Humans | 96 | 2023 | 761423 | 0.120 |
Why?
|
| Tumor Suppressor Protein p14ARF | 2 | 2006 | 84 | 0.120 |
Why?
|
| Polycystic Kidney Diseases | 1 | 1996 | 133 | 0.120 |
Why?
|
| Lymph Nodes | 2 | 2006 | 3466 | 0.120 |
Why?
|
| Pancreatic Diseases | 1 | 1997 | 343 | 0.120 |
Why?
|
| Female | 66 | 2023 | 392581 | 0.120 |
Why?
|
| Middle Aged | 51 | 2021 | 220826 | 0.120 |
Why?
|
| Amino Acid Substitution | 1 | 1999 | 1738 | 0.120 |
Why?
|
| Prognosis | 12 | 2021 | 29620 | 0.120 |
Why?
|
| DNA Polymerase I | 1 | 1994 | 43 | 0.120 |
Why?
|
| Antineoplastic Agents, Alkylating | 2 | 2009 | 617 | 0.120 |
Why?
|
| Fluorouracil | 3 | 2016 | 1639 | 0.120 |
Why?
|
| Polymerase Chain Reaction | 9 | 2011 | 6086 | 0.120 |
Why?
|
| Adaptor Proteins, Signal Transducing | 12 | 2015 | 2898 | 0.110 |
Why?
|
| Aged | 41 | 2021 | 169235 | 0.110 |
Why?
|
| BRCA1 Protein | 3 | 2000 | 1155 | 0.110 |
Why?
|
| Disease Progression | 8 | 2021 | 13502 | 0.110 |
Why?
|
| Carcinoma in Situ | 3 | 2005 | 791 | 0.110 |
Why?
|
| Endosonography | 1 | 1997 | 609 | 0.110 |
Why?
|
| Male | 59 | 2023 | 360736 | 0.110 |
Why?
|
| Vasculitis | 1 | 1997 | 521 | 0.110 |
Why?
|
| Carcinoma | 4 | 2015 | 2330 | 0.100 |
Why?
|
| DNA Mutational Analysis | 9 | 2008 | 4110 | 0.100 |
Why?
|
| Adult | 42 | 2021 | 221148 | 0.100 |
Why?
|
| Carcinoma, Pancreatic Ductal | 3 | 2009 | 1726 | 0.100 |
Why?
|
| Enterocytes | 4 | 2007 | 220 | 0.100 |
Why?
|
| Chemotherapy, Adjuvant | 5 | 2021 | 3514 | 0.100 |
Why?
|
| DNA Repair Enzymes | 2 | 2015 | 346 | 0.100 |
Why?
|
| Intestinal Mucosa | 8 | 2008 | 3030 | 0.090 |
Why?
|
| Survival Analysis | 8 | 2009 | 10089 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 1994 | 1165 | 0.090 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 1922 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 2011 | 247 | 0.090 |
Why?
|
| Cysts | 1 | 1996 | 681 | 0.090 |
Why?
|
| Neoplasm Staging | 7 | 2016 | 11106 | 0.090 |
Why?
|
| Neoadjuvant Therapy | 1 | 2021 | 2826 | 0.090 |
Why?
|
| Codon | 3 | 1999 | 602 | 0.090 |
Why?
|
| Isoenzymes | 3 | 2004 | 1688 | 0.090 |
Why?
|
| Mutation, Missense | 3 | 2008 | 2571 | 0.090 |
Why?
|
| Adenocarcinoma, Mucinous | 2 | 2009 | 517 | 0.090 |
Why?
|
| rho GTP-Binding Proteins | 2 | 2008 | 276 | 0.090 |
Why?
|
| Bacitracin | 1 | 1989 | 24 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 4 | 2007 | 4741 | 0.080 |
Why?
|
| Fibromatosis, Aggressive | 1 | 2010 | 126 | 0.080 |
Why?
|
| Carrier Proteins | 11 | 2005 | 4936 | 0.080 |
Why?
|
| Proctocolectomy, Restorative | 2 | 2001 | 190 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2010 | 2423 | 0.080 |
Why?
|
| Captopril | 1 | 1989 | 265 | 0.080 |
Why?
|
| Nuclear Proteins | 11 | 2015 | 5794 | 0.080 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 3 | 2004 | 318 | 0.080 |
Why?
|
| Pilomatrixoma | 2 | 2005 | 24 | 0.080 |
Why?
|
| HMGA1a Protein | 1 | 2008 | 61 | 0.080 |
Why?
|
| Sebaceous Gland Neoplasms | 1 | 2008 | 40 | 0.080 |
Why?
|
| Pancreatic Ducts | 2 | 2008 | 329 | 0.080 |
Why?
|
| p21-Activated Kinases | 1 | 2008 | 128 | 0.070 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11740 | 0.070 |
Why?
|
| Leucine | 1 | 1989 | 548 | 0.070 |
Why?
|
| Cardia | 1 | 2007 | 60 | 0.070 |
Why?
|
| Hair Diseases | 2 | 2005 | 72 | 0.070 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 3 | 2006 | 3779 | 0.070 |
Why?
|
| Prevalence | 2 | 2022 | 15717 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2016 | 8545 | 0.070 |
Why?
|
| Liver Diseases | 1 | 1996 | 1297 | 0.070 |
Why?
|
| Carcinoid Tumor | 1 | 2009 | 224 | 0.070 |
Why?
|
| Leucovorin | 1 | 2009 | 642 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2010 | 727 | 0.070 |
Why?
|
| Keratin-20 | 1 | 2006 | 31 | 0.070 |
Why?
|
| Keratin-7 | 1 | 2006 | 55 | 0.070 |
Why?
|
| Disease-Free Survival | 3 | 2016 | 6814 | 0.070 |
Why?
|
| Intestinal Polyps | 2 | 2008 | 104 | 0.070 |
Why?
|
| Estrogen Receptor beta | 1 | 2007 | 168 | 0.070 |
Why?
|
| Risk Assessment | 6 | 2021 | 23990 | 0.060 |
Why?
|
| Heterozygote | 5 | 2003 | 2803 | 0.060 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2000 | 592 | 0.060 |
Why?
|
| Actomyosin | 1 | 2006 | 109 | 0.060 |
Why?
|
| Camptothecin | 1 | 2009 | 590 | 0.060 |
Why?
|
| Esophagogastric Junction | 1 | 2007 | 347 | 0.060 |
Why?
|
| Liver Neoplasms | 3 | 2008 | 4320 | 0.060 |
Why?
|
| Coumestrol | 1 | 2004 | 1 | 0.060 |
Why?
|
| Skin Neoplasms | 5 | 2009 | 5819 | 0.060 |
Why?
|
| Phenanthrenes | 1 | 2005 | 66 | 0.060 |
Why?
|
| Fungal Proteins | 3 | 2005 | 910 | 0.060 |
Why?
|
| Genistein | 1 | 2004 | 86 | 0.060 |
Why?
|
| Phytoestrogens | 1 | 2004 | 59 | 0.060 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2006 | 234 | 0.060 |
Why?
|
| Carcinoembryonic Antigen | 1 | 2006 | 337 | 0.060 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2008 | 361 | 0.060 |
Why?
|
| Cadherins | 2 | 2006 | 904 | 0.060 |
Why?
|
| Intestinal Polyposis | 1 | 2004 | 42 | 0.060 |
Why?
|
| DNA Glycosylases | 1 | 2004 | 125 | 0.060 |
Why?
|
| Mice | 22 | 2023 | 81509 | 0.060 |
Why?
|
| Immunoenzyme Techniques | 3 | 2007 | 1706 | 0.060 |
Why?
|
| Chromosomal Instability | 1 | 2004 | 178 | 0.060 |
Why?
|
| Bloom Syndrome | 1 | 2003 | 10 | 0.060 |
Why?
|
| Allelic Imbalance | 1 | 2004 | 77 | 0.060 |
Why?
|
| Mice, Nude | 5 | 2008 | 3614 | 0.060 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 785 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 11 | 2023 | 22163 | 0.050 |
Why?
|
| Diagnostic Imaging | 1 | 1997 | 3530 | 0.050 |
Why?
|
| Pedigree | 9 | 2003 | 4589 | 0.050 |
Why?
|
| Estrogen Receptor alpha | 1 | 2007 | 582 | 0.050 |
Why?
|
| Breast Neoplasms | 7 | 2009 | 21012 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 3 | 2008 | 2054 | 0.050 |
Why?
|
| Phosphorylation | 5 | 2010 | 8320 | 0.050 |
Why?
|
| Disease Models, Animal | 4 | 2023 | 18247 | 0.050 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2001 | 1085 | 0.050 |
Why?
|
| Sigmoid Neoplasms | 2 | 2004 | 54 | 0.050 |
Why?
|
| Animals | 25 | 2023 | 168441 | 0.050 |
Why?
|
| Biopsy | 5 | 2018 | 6766 | 0.050 |
Why?
|
| Gastrointestinal Transit | 1 | 2002 | 99 | 0.050 |
Why?
|
| Genomic Instability | 1 | 2005 | 709 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2000 | 12125 | 0.050 |
Why?
|
| Pouchitis | 1 | 2001 | 64 | 0.050 |
Why?
|
| Lymphatic Metastasis | 2 | 2006 | 2914 | 0.050 |
Why?
|
| Nausea | 1 | 2023 | 679 | 0.050 |
Why?
|
| Predictive Value of Tests | 5 | 2015 | 15262 | 0.040 |
Why?
|
| New England | 1 | 2023 | 1053 | 0.040 |
Why?
|
| Gastroenterology | 1 | 2007 | 577 | 0.040 |
Why?
|
| Glucagon | 1 | 2002 | 532 | 0.040 |
Why?
|
| Genes, DCC | 1 | 1999 | 10 | 0.040 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2006 | 1115 | 0.040 |
Why?
|
| Carcinoma, Medullary | 1 | 2000 | 115 | 0.040 |
Why?
|
| Ontario | 3 | 2008 | 398 | 0.040 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 2003 | 646 | 0.040 |
Why?
|
| Molecular Sequence Data | 7 | 2000 | 17644 | 0.040 |
Why?
|
| Arrhythmias, Cardiac | 1 | 1989 | 2246 | 0.040 |
Why?
|
| Base Sequence | 6 | 1996 | 12450 | 0.040 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2005 | 560 | 0.040 |
Why?
|
| Peutz-Jeghers Syndrome | 1 | 1999 | 59 | 0.040 |
Why?
|
| Gastrointestinal Agents | 1 | 2004 | 510 | 0.040 |
Why?
|
| Blood Proteins | 1 | 2004 | 1180 | 0.040 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2008 | 2863 | 0.040 |
Why?
|
| DNA, Satellite | 2 | 1996 | 67 | 0.040 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2004 | 17912 | 0.040 |
Why?
|
| Hyperplasia | 4 | 2008 | 1152 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2009 | 2871 | 0.040 |
Why?
|
| Cell Adhesion Molecules | 1 | 2005 | 1600 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 17 | 2 | 2004 | 418 | 0.040 |
Why?
|
| Nucleic Acid Hybridization | 3 | 2007 | 1306 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2005 | 1509 | 0.040 |
Why?
|
| Proteome | 1 | 2008 | 1862 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2002 | 1133 | 0.040 |
Why?
|
| Endoscopy, Gastrointestinal | 2 | 2001 | 874 | 0.040 |
Why?
|
| Frozen Sections | 1 | 1998 | 153 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2023 | 80582 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2004 | 1651 | 0.040 |
Why?
|
| Interleukin-10 | 1 | 2023 | 1175 | 0.040 |
Why?
|
| Neoplasms | 2 | 2004 | 22164 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2003 | 6132 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 1998 | 386 | 0.040 |
Why?
|
| Abdominal Pain | 1 | 2023 | 1071 | 0.040 |
Why?
|
| Cyclins | 2 | 1998 | 594 | 0.040 |
Why?
|
| Antigens, Neoplasm | 1 | 2005 | 1994 | 0.030 |
Why?
|
| Cyclooxygenase 2 | 3 | 2004 | 597 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 1 | 2004 | 1960 | 0.030 |
Why?
|
| Cell Movement | 2 | 2008 | 5203 | 0.030 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2012 | 5305 | 0.030 |
Why?
|
| Exons | 2 | 2000 | 2393 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 2 | 2004 | 3490 | 0.030 |
Why?
|
| Tyrosine | 3 | 2005 | 1440 | 0.030 |
Why?
|
| Esophagoscopy | 1 | 2018 | 396 | 0.030 |
Why?
|
| Genes, BRCA1 | 1 | 2000 | 764 | 0.030 |
Why?
|
| BRCA2 Protein | 2 | 2000 | 805 | 0.030 |
Why?
|
| Gene Expression Profiling | 3 | 2007 | 9418 | 0.030 |
Why?
|
| Intestines | 1 | 2004 | 1909 | 0.030 |
Why?
|
| src-Family Kinases | 2 | 2010 | 535 | 0.030 |
Why?
|
| Stomach Neoplasms | 1 | 2005 | 1459 | 0.030 |
Why?
|
| Genetic Markers | 4 | 2007 | 2613 | 0.030 |
Why?
|
| Treatment Outcome | 5 | 2021 | 64651 | 0.030 |
Why?
|
| Vanadates | 2 | 2005 | 82 | 0.030 |
Why?
|
| Europe | 2 | 2000 | 3423 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2023 | 4354 | 0.030 |
Why?
|
| Intestine, Small | 3 | 2006 | 1205 | 0.030 |
Why?
|
| Breast Diseases | 1 | 1998 | 442 | 0.030 |
Why?
|
| Risk Factors | 9 | 2021 | 74167 | 0.030 |
Why?
|
| Combined Modality Therapy | 3 | 2016 | 8529 | 0.030 |
Why?
|
| Melanoma | 2 | 2006 | 5709 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1999 | 1967 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-akt | 3 | 2008 | 2455 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 1997 | 506 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 1999 | 605 | 0.030 |
Why?
|
| Antineoplastic Agents | 3 | 2012 | 13637 | 0.030 |
Why?
|
| Cholestasis | 1 | 1997 | 378 | 0.030 |
Why?
|
| Head and Neck Neoplasms | 1 | 2008 | 2892 | 0.030 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2004 | 2803 | 0.030 |
Why?
|
| Computational Biology | 2 | 2004 | 3517 | 0.030 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2001 | 926 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2004 | 3612 | 0.030 |
Why?
|
| Glioblastoma | 1 | 2008 | 3482 | 0.030 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2008 | 2422 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 3 | 2008 | 3589 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2023 | 3207 | 0.030 |
Why?
|
| Child | 6 | 2023 | 80162 | 0.030 |
Why?
|
| Radiographic Image Enhancement | 1 | 1997 | 876 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2009 | 10766 | 0.030 |
Why?
|
| Dinoprostone | 2 | 2006 | 597 | 0.030 |
Why?
|
| RNA, Messenger | 3 | 2008 | 12796 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 9179 | 0.020 |
Why?
|
| Immunoprecipitation | 2 | 2004 | 878 | 0.020 |
Why?
|
| Gene Targeting | 1 | 1995 | 838 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 1997 | 1626 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2003 | 4912 | 0.020 |
Why?
|
| Kidney Diseases | 2 | 2006 | 2092 | 0.020 |
Why?
|
| Case-Control Studies | 4 | 2018 | 22168 | 0.020 |
Why?
|
| Signal Transduction | 6 | 2008 | 23441 | 0.020 |
Why?
|
| Phenotype | 6 | 2008 | 16606 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2002 | 20556 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 7 | 2 | 2004 | 310 | 0.020 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2006 | 2273 | 0.020 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 12970 | 0.020 |
Why?
|
| Adenosine Triphosphatases | 1 | 2015 | 834 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 1999 | 1974 | 0.020 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2004 | 4021 | 0.020 |
Why?
|
| Statistics, Nonparametric | 2 | 2008 | 2851 | 0.020 |
Why?
|
| Models, Genetic | 3 | 2007 | 3446 | 0.020 |
Why?
|
| Prospective Studies | 4 | 2009 | 54415 | 0.020 |
Why?
|
| Brain Neoplasms | 2 | 2009 | 9031 | 0.020 |
Why?
|
| Homozygote | 2 | 2006 | 1796 | 0.020 |
Why?
|
| Probability | 2 | 2007 | 2478 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2007 | 11526 | 0.020 |
Why?
|
| Peptides | 1 | 2002 | 4345 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2007 | 7389 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5115 | 0.020 |
Why?
|
| Acute Disease | 2 | 1997 | 7238 | 0.020 |
Why?
|
| Aminopeptidases | 1 | 1989 | 95 | 0.020 |
Why?
|
| DNA | 1 | 2003 | 7219 | 0.020 |
Why?
|
| Proteins | 1 | 2004 | 6032 | 0.020 |
Why?
|
| Cell Adhesion | 2 | 2006 | 3087 | 0.020 |
Why?
|
| In Situ Hybridization | 2 | 2004 | 1900 | 0.020 |
Why?
|
| Back | 1 | 2008 | 64 | 0.020 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13449 | 0.020 |
Why?
|
| Mice, Mutant Strains | 2 | 2006 | 1750 | 0.020 |
Why?
|
| Mice, Transgenic | 3 | 2007 | 9535 | 0.020 |
Why?
|
| Keratoacanthoma | 1 | 2008 | 33 | 0.020 |
Why?
|
| Digoxin | 1 | 1989 | 246 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2011 | 694 | 0.020 |
Why?
|
| Genotype | 3 | 2005 | 13009 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2009 | 319 | 0.020 |
Why?
|
| Genome | 2 | 2007 | 1740 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2009 | 9277 | 0.020 |
Why?
|
| Guinea Pigs | 1 | 1989 | 1317 | 0.020 |
Why?
|
| Feces | 1 | 1994 | 1497 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2008 | 6231 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2008 | 868 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 1989 | 1380 | 0.020 |
Why?
|
| Time Factors | 3 | 2021 | 39975 | 0.020 |
Why?
|
| Mice, Knockout | 4 | 2006 | 14409 | 0.020 |
Why?
|
| Metaplasia | 1 | 2007 | 322 | 0.020 |
Why?
|
| Receptors, Prostaglandin | 1 | 2006 | 53 | 0.020 |
Why?
|
| Lipoxygenase | 1 | 2006 | 72 | 0.020 |
Why?
|
| Tyrphostins | 1 | 2006 | 63 | 0.020 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1995 | 1551 | 0.020 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2006 | 42 | 0.020 |
Why?
|
| Egtazic Acid | 1 | 2006 | 169 | 0.020 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2006 | 43 | 0.020 |
Why?
|
| Up-Regulation | 2 | 2006 | 4124 | 0.020 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2006 | 87 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2008 | 16979 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 2 | 1998 | 360 | 0.020 |
Why?
|
| Survival Rate | 3 | 2008 | 12720 | 0.020 |
Why?
|
| Colectomy | 2 | 2004 | 688 | 0.020 |
Why?
|
| Algorithms | 2 | 2008 | 14026 | 0.020 |
Why?
|
| Myosin Light Chains | 1 | 2006 | 121 | 0.020 |
Why?
|
| Pancreas, Exocrine | 1 | 2006 | 48 | 0.020 |
Why?
|
| Cardiovascular Diseases | 2 | 2009 | 15498 | 0.020 |
Why?
|
| Chromosome Mapping | 3 | 2000 | 4638 | 0.020 |
Why?
|
| Genes, Neoplasm | 1 | 2007 | 370 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 615 | 0.020 |
Why?
|
| Rosmarinus | 1 | 2005 | 1 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2008 | 641 | 0.020 |
Why?
|
| Cardiac Myosins | 1 | 2006 | 128 | 0.020 |
Why?
|
| Muscle Relaxants, Central | 1 | 2006 | 93 | 0.020 |
Why?
|
| Thorax | 1 | 2008 | 555 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2008 | 815 | 0.020 |
Why?
|
| Rosaniline Dyes | 1 | 2004 | 48 | 0.020 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2004 | 69 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2006 | 477 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 2007 | 657 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 695 | 0.010 |
Why?
|
| Multivariate Analysis | 3 | 2004 | 12058 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1997 | 5970 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2008 | 1834 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1667 | 0.010 |
Why?
|
| Macrophages, Peritoneal | 1 | 2004 | 238 | 0.010 |
Why?
|
| Sensitivity and Specificity | 3 | 2004 | 14664 | 0.010 |
Why?
|
| Proportional Hazards Models | 2 | 2011 | 12456 | 0.010 |
Why?
|
| Lysophospholipids | 1 | 2006 | 338 | 0.010 |
Why?
|
| False Negative Reactions | 1 | 2004 | 573 | 0.010 |
Why?
|
| Sequence Deletion | 2 | 2000 | 1494 | 0.010 |
Why?
|
| GPI-Linked Proteins | 1 | 2005 | 468 | 0.010 |
Why?
|
| Amides | 1 | 2006 | 449 | 0.010 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2004 | 302 | 0.010 |
Why?
|
| Clathrin | 1 | 2004 | 257 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 2004 | 1141 | 0.010 |
Why?
|
| Cyclin D1 | 1 | 2005 | 451 | 0.010 |
Why?
|
| Jurkat Cells | 1 | 2004 | 740 | 0.010 |
Why?
|
| Extremities | 1 | 2008 | 867 | 0.010 |
Why?
|
| Proglucagon | 1 | 2002 | 32 | 0.010 |
Why?
|
| Registries | 2 | 1997 | 8223 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 2005 | 629 | 0.010 |
Why?
|
| Remission Induction | 1 | 2008 | 2395 | 0.010 |
Why?
|
| Atrophy | 1 | 2007 | 1633 | 0.010 |
Why?
|
| Ovariectomy | 1 | 2004 | 614 | 0.010 |
Why?
|
| Aspartic Acid | 1 | 2004 | 576 | 0.010 |
Why?
|
| Mohs Surgery | 1 | 2005 | 222 | 0.010 |
Why?
|
| Membrane Proteins | 3 | 2004 | 7856 | 0.010 |
Why?
|
| Young Adult | 1 | 2009 | 59207 | 0.010 |
Why?
|
| Abdomen | 1 | 2008 | 1128 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 2 | 1997 | 1062 | 0.010 |
Why?
|
| Coloring Agents | 1 | 2004 | 559 | 0.010 |
Why?
|
| Sex Factors | 1 | 1996 | 10548 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 2004 | 750 | 0.010 |
Why?
|
| Sulindac | 1 | 2001 | 29 | 0.010 |
Why?
|
| Cell Proliferation | 2 | 2008 | 10441 | 0.010 |
Why?
|
| Follow-Up Studies | 4 | 2009 | 39117 | 0.010 |
Why?
|
| Endoscopy, Digestive System | 1 | 2004 | 351 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 2004 | 553 | 0.010 |
Why?
|
| Syndrome | 1 | 2008 | 3268 | 0.010 |
Why?
|
| Cyclooxygenase 1 | 1 | 2001 | 97 | 0.010 |
Why?
|
| Observer Variation | 1 | 2007 | 2605 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 1992 | 0.010 |
Why?
|
| Integrases | 1 | 2003 | 516 | 0.010 |
Why?
|
| Glycine | 1 | 2004 | 666 | 0.010 |
Why?
|
| Chromosomes | 1 | 2004 | 577 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 1647 | 0.010 |
Why?
|
| Chromosome Aberrations | 1 | 2007 | 1771 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2006 | 1201 | 0.010 |
Why?
|
| Mass Spectrometry | 1 | 2008 | 2192 | 0.010 |
Why?
|
| Colonoscopy | 1 | 2009 | 1394 | 0.010 |
Why?
|
| Single-Blind Method | 1 | 2004 | 1571 | 0.010 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2004 | 629 | 0.010 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 6479 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 2265 | 0.010 |
Why?
|
| Furans | 1 | 2001 | 201 | 0.010 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 750 | 0.010 |
Why?
|
| Adolescent | 5 | 2005 | 88313 | 0.010 |
Why?
|
| Estrogens | 1 | 2007 | 1522 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2006 | 1474 | 0.010 |
Why?
|
| Genetic Engineering | 1 | 2006 | 933 | 0.010 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2008 | 3602 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 892 | 0.010 |
Why?
|
| Gene Dosage | 1 | 2004 | 1218 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2831 | 0.010 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2002 | 364 | 0.010 |
Why?
|
| Ubiquitin | 1 | 2004 | 839 | 0.010 |
Why?
|
| Models, Biological | 2 | 2007 | 9469 | 0.010 |
Why?
|
| Quinazolines | 1 | 2006 | 1371 | 0.010 |
Why?
|
| Reproducibility of Results | 2 | 2007 | 20093 | 0.010 |
Why?
|
| Age Factors | 1 | 1996 | 18400 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2002 | 557 | 0.010 |
Why?
|
| Genetic Testing | 2 | 2005 | 3538 | 0.010 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2004 | 1784 | 0.010 |
Why?
|
| Cattle | 1 | 2004 | 3848 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3304 | 0.010 |
Why?
|
| Terminology as Topic | 1 | 2006 | 1535 | 0.010 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2003 | 611 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 19 | 1 | 1999 | 350 | 0.010 |
Why?
|
| Transcriptional Activation | 1 | 2004 | 1756 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4852 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2004 | 3093 | 0.010 |
Why?
|
| Catalytic Domain | 1 | 2000 | 705 | 0.010 |
Why?
|
| Gastrointestinal Diseases | 1 | 2006 | 1199 | 0.010 |
Why?
|
| Databases, Genetic | 1 | 2004 | 1742 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2004 | 3647 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 4575 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 1998 | 329 | 0.010 |
Why?
|
| Cohort Studies | 3 | 2004 | 41446 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 2001 | 1791 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2004 | 3810 | 0.010 |
Why?
|
| Family | 2 | 2000 | 3197 | 0.010 |
Why?
|
| Colostomy | 1 | 1997 | 105 | 0.010 |
Why?
|
| Introns | 1 | 1999 | 981 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2004 | 2208 | 0.010 |
Why?
|
| Viral Proteins | 1 | 2003 | 1803 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2006 | 6309 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2005 | 2908 | 0.010 |
Why?
|
| Morbidity | 1 | 2001 | 1750 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1999 | 902 | 0.010 |
Why?
|
| Forecasting | 1 | 2004 | 2928 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2004 | 2448 | 0.010 |
Why?
|
| Cell Membrane | 1 | 2005 | 3687 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2007 | 3667 | 0.010 |
Why?
|
| Medical Oncology | 1 | 2007 | 2321 | 0.010 |
Why?
|
| Family Health | 1 | 2000 | 1257 | 0.010 |
Why?
|
| Preoperative Care | 1 | 2004 | 2242 | 0.010 |
Why?
|
| Aspirin | 1 | 2006 | 3134 | 0.010 |
Why?
|
| Proteomics | 1 | 2008 | 3845 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2000 | 1079 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2000 | 2382 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2005 | 4001 | 0.010 |
Why?
|
| Pyridines | 1 | 2006 | 2875 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1995 | 445 | 0.010 |
Why?
|
| Infant | 1 | 1996 | 36205 | 0.010 |
Why?
|
| Molecular Biology | 1 | 1997 | 578 | 0.010 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2000 | 612 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1989 | 8487 | 0.010 |
Why?
|
| Feasibility Studies | 1 | 2004 | 5246 | 0.010 |
Why?
|
| Protein Binding | 1 | 2006 | 9352 | 0.010 |
Why?
|
| Meiosis | 1 | 1995 | 328 | 0.010 |
Why?
|
| Fibroblasts | 1 | 2003 | 4140 | 0.010 |
Why?
|
| Pancreas | 1 | 2000 | 1690 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1996 | 42254 | 0.010 |
Why?
|
| Protein Biosynthesis | 1 | 2000 | 2114 | 0.010 |
Why?
|
| Genetic Counseling | 1 | 1997 | 627 | 0.010 |
Why?
|
| Genomics | 1 | 2008 | 5820 | 0.010 |
Why?
|
| Calcium | 1 | 2006 | 5727 | 0.010 |
Why?
|
| Longevity | 1 | 2000 | 1065 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1994 | 535 | 0.010 |
Why?
|
| Ovarian Neoplasms | 1 | 2009 | 4876 | 0.010 |
Why?
|
| Recurrence | 1 | 2004 | 8469 | 0.010 |
Why?
|
| Neoplasm Transplantation | 1 | 1995 | 2016 | 0.010 |
Why?
|
| Oncogenes | 1 | 1997 | 1222 | 0.010 |
Why?
|
| RNA, Viral | 1 | 2000 | 2846 | 0.010 |
Why?
|
| Gene Expression | 1 | 2004 | 7584 | 0.010 |
Why?
|
| Species Specificity | 1 | 1995 | 2416 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2001 | 5868 | 0.010 |
Why?
|
| Retinoblastoma Protein | 1 | 1994 | 672 | 0.010 |
Why?
|
| Cell Line | 1 | 2004 | 15605 | 0.010 |
Why?
|
| Incidence | 1 | 2008 | 21341 | 0.010 |
Why?
|
| DNA Replication | 1 | 1997 | 1418 | 0.010 |
Why?
|
| Chromosome Deletion | 1 | 1994 | 1387 | 0.010 |
Why?
|
| Contrast Media | 1 | 2002 | 5311 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2000 | 3447 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 2002 | 5492 | 0.000 |
Why?
|
| Cholangiocarcinoma | 1 | 1994 | 552 | 0.000 |
Why?
|
| Health Education | 1 | 1995 | 1052 | 0.000 |
Why?
|
| Transplantation, Heterologous | 1 | 1995 | 2386 | 0.000 |
Why?
|
| Pancreatitis | 1 | 1994 | 1096 | 0.000 |
Why?
|
| Chronic Disease | 1 | 2001 | 9320 | 0.000 |
Why?
|
| Colon | 1 | 1994 | 1792 | 0.000 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2002 | 8999 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1995 | 3712 | 0.000 |
Why?
|
| Referral and Consultation | 1 | 1995 | 3600 | 0.000 |
Why?
|
| Databases, Factual | 1 | 1995 | 7956 | 0.000 |
Why?
|